Jaundice caused by hyperbilirubinemia is common during the neonatal period. Yet there are only a few Population-based studies evaluating assessment, management, and incidence of jaundice and the need for phototherapy among otherwise healthy neonates.
A recent study prospectively explored these aspects in a primary care setting via evaluating care as usual during the control phase of a stepped wedge cluster randomized controlled trial.
The study included a Screening and Treatment to Reduce Severe Hyperbilirubinaemia in Infants in Primary care (STARSHIP) Trial. It included Healthy neonates in seven primary care birth centers (PCBCs) in the Netherlands between July 2018 and March 2020.
Inclusion criteria for neonates were:
Outcomes included the visual assessment to detect jaundice, jaundice incidence and management, and the need for phototherapy treatment in the primary care setting.
The results were as follows-
This study showed that-
Thus, quality improvement initiatives are needed, including alternative approaches to recognizing potentially severe hyperbilirubinemia.
van der Geest BAM, de Mol MJS, Barendse ISA. et al. Assessment, management, and incidence of neonatal jaundice in healthy neonates cared for in primary care: a prospective cohort study. Sci Rep. 2022;12. https://doi.org/10.1038/s41598-022-17933-2
Subscribe To Our Newsletter
Filter out the noise and nurture your inbox with health and wellness advice that's inclusive and rooted in medical expertise.
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please update your details
Please login to comment on this article